(Reuters) -Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on ...

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Europe's STOXX 600 eked out minor gains on Tuesday led by gains in industrials as investors assessed a slew of downbeat ...

Astrazeneca has raised its guidance for the full year despite issues surrounding its presence in China according to today's ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to ...

AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...

AstraZeneca (AZN.L, AZN) reported third quarter profit to owners of the Parent of $1.43 billion compared to $1.37 billion, last year.

The post-election advance for US markets continued last night, while Bitcoin surged as much as 10% to above $88,000. The Dow ...